decentralized clinical trial
Clario publishes roadmap for using artificial intelligence (AI) to improve patients' experience in decentralized clinical trials (DCTs)
Clario, a technology company that delivers the leading endpoint solutions for decentralized, hybrid and site-based clinical trials, today published a manuscript in Nature Medicine that outlines how AI can improve patients' experience in DCTs. This comes as remote trials continue to rise in popularity, placing increased responsibility on participants. The study explores how AI automation can support improvements in digital health user interfaces. "AI is being used to enhance user experience in customer-facing applications across many industries," said Kevin Thomas, Ph.D., Director of Artificial Intelligence at Clario, one of the researchers. "Adopting this approach in clinical trials means we can help more patients to enroll, empower them to complete trials without undue burden, and ensure they are able to submit high-quality health assessments throughout their participation."
- Information Technology > Artificial Intelligence > Applied AI (0.42)
- Information Technology > Communications > Social Media (0.33)
Artificial intelligence can improve patients' experience in decentralized clinical trials - Nature Medicine
Computer vision is a domain of AI that enables the automatic assessment of images and videos. Many mobile banking apps use computer vision to coach customers to take photos of their checks for electronic deposits. If you hold the camera too far from the check or the lighting is too dark, the app will provide real-time advice about the required adjustments. The same could be done for user-submitted photos and videos in clinical trials; this approach has already been tested in telemedicine8. If a patient's entire body needs to be visible in the video, this could be confirmed automatically while the video is being captured in the trial's mobile application, allowing for immediate adjustments.
- Banking & Finance (1.00)
- Health & Medicine > Pharmaceuticals & Biotechnology (0.66)
Transforming Patient Health: The Power of Data Science in Pharmaceuticals - Dataconomy
By leveraging Data Science, AI, and other digital technologies, the healthcare industry could build complementary health solutions that are personalized to the specific needs of patients. Here is how and why. The world population grows by more than 80 million per year, according to a 2017 report by the United Nations. By 2050, there will be 10 billion people on this planet and people over the age of 60 years and above are expected to double. It's clear that a growing and aging world population needs better and more sustainable solutions for health and nutrition.
- Research Report > New Finding (0.34)
- Research Report > Experimental Study (0.34)
- Information Technology > Data Science (1.00)
- Information Technology > Artificial Intelligence (1.00)